Two decades ago, only about 5% of general surgical procedures in China were performed using laparoscopic techniques. According to the latest statistics from the "Blue Book on Minimally Invasive Surgery in China (2023)," this proportion has risen to over 75%, with minimally invasive rates exceeding 90% for mainstream procedures such as gastrectomy and cholecystectomy. Behind these figures lie significant benefits for patients, including reduced trauma, shorter hospital stays, and faster postoperative recovery, underscoring that minimally invasive surgery has become the mainstream direction in clinical surgical practice in China.
However, although laparoscopic technology has become the “gold standard” in thoracic and abdominal surgery, the corresponding talent training system still faces multiple challenges: young physicians lack sufficient clinical practice opportunities, while ethical concerns and medical risks remain high, leading to the widespread phenomenon of “novices hesitant to operate and mentors reluctant to delegate”; traditional training devices often feature distorted anatomical structures, lack haptic feedback, and fail to simulate real-life bleeding and tissue tension, resulting in a significant disconnect between training and clinical practice; meanwhile, the industry still lacks a systematic, standardized, and quantifiable teaching and assessment framework, leading to low learning efficiency and prolonged professional development for physicians, which hinders the large-scale, high-quality cultivation of minimally invasive surgical talent.
Confronting these core pain points,Cydeo MedicalGuided by real clinical needs and leveraging interdisciplinary innovation in medicine and engineering, we have independently developedHigh-Fidelity Laparoscopic Ex Vivo Organ Surgical Training System, providing for resident physicians, young physicians, and specialized talentEnd-to-End, Standardized, High-FidelityComprehensive Laparoscopic Skills Training Solution, Dedicated to Leveraging Technological Innovation to Address the Challenge of Cultivating Minimally Invasive Surgical Talent.
Friday, April 17, 19:00, VCBeat's 137th New Product Review featuresTang Bo, Founder of Cideou Medical; Liu Ke, Deputy General Manager and Technical Director of Cideou Medical; Du Yapeng, Assistant to the General Manager of Cideou Medical, providing an in-depth discussion of the technical details and industry value of the ex vivo organ laparoscopic surgical training system during the live broadcast.
Scan the QR code in the poster below to register for the live stream

The ex vivo organ laparoscopic surgery training system is an innovative medical education product based on ex vivo animal organs, designed for the training of clinicians in laparoscopy and digestive endoscopy.

This product is inXi'an Jiaotong University, Hebei Medical University, Dalian Medical University, Shandong University, Sichuan Universityand its affiliated hospitalsand other institutions have all demonstrated highly successful use cases.

Tang Bo
Founder of CytoMed
Tang Bo, Senior Engineer, is the founder of Xi’an Saideou Medical Research Institute Co., Ltd. He has presided over or participated in five provincial- and ministerial-level scientific research projects. His accolades include one First Prize, one Second Prize, and one Third Prize for Scientific and Technological Progress of Shaanxi Province, as well as the First Prize in the Shaanxi Division of the China Innovation and Entrepreneurship Competition and the First Prize in the China Medical Device Innovation Competition. He has published more than 20 core scientific and technical papers in Chinese and English, serves as Associate Editor-in-Chief of *Clinical Practice of Magnetic Surgery*, holds over 60 authorized patents, and has achieved cumulative technology transfer revenues exceeding RMB 15 million.

Liu Ke
Deputy General Manager and Technical Director, Sideou Medical
Liu Ke, Intermediate Engineer, serves as Deputy General Manager and Technical Director at Xi’an Saideou Medical Research Institute Co., Ltd. He oversees the company’s R&D projects. A graduate of the Air Force Engineering University, Mr. Liu has dedicated over a decade to the research and development of medical devices and the translation of medical-engineering integration achievements. He has participated in nearly ten provincial and ministerial-level projects, secured eight authorized patents, and obtained three software copyrights.Mr. Liu has successfully developed and commercialized several innovative products, including: the Magnetic Traction Surgical Field Exposure System (approved through the Innovative Medical Device pathway and granted a Class II Medical Device Registration Certificate); the Wireless Cholangiography Contrast Injection System (granted national Class II Medical Device Registration); the Magnetic Retractor (filed under National Class I Medical Device Recordation); and the Magnetic Digestive Tract Anastomosis Device (approved through the Innovative Medical Device pathway and currently in clinical trial stages). Additionally, he has facilitated the translation of high-fidelity full-organ and single-organ laparoscopic surgical training systems. These products have been promoted and applied across multiple provinces and municipalities nationwide. He has organized over one hundred training sessions, training nearly 10,000 professionals, with the cumulative value of translated products exceeding tens of millions of yuan.

Du Yapeng
Assistant to the General Manager, Saideou Medical
Du Yapeng, Assistant to the General Manager of Xi’an Saideou Medical Research Institute Co., Ltd. He is primarily responsible for academic affairs related to products, establishing a comprehensive intellectual property (IP) management system aligned with the company’s product portfolio. He has filed 110 IP applications, secured over 90 grants, submitted five provincial- and municipal-level key research project proposals, and published four articles.
About Sideou Medical
Xi’an Saideou Medical Research Institute Co., Ltd. was established in 2019 in the Xi’an High-Tech Industrial Development Zone and holds controlling interests in two subsidiaries. As a national high-tech enterprise, the company focuses on the research, development, and translation of magnetic surgery and smart healthcare technologies. Guided by clinical needs, it adheres to a model integrating medical practice, research, and enterprise collaboration, as well as industry-academia-research development. With a multidisciplinary professional team, the company specializes in the R&D, manufacturing, and sales of medical devices and teaching aids.
The company has undertaken more than ten key provincial and municipal R&D projects, filed over 120 patent applications (with more than 90 granted), formulated one local standard, and received numerous honors, including the Shaanxi Provincial Science and Technology Award and first prize in an Innovation and Entrepreneurship Competition. It has established stable collaborations with multiple national key laboratories and spearheaded the establishment of a collaborative innovation platform and an industry alliance.
Through industry-academia-research collaboration, three Class II medical devices with fully independent intellectual property rights have been successfully commercialized, two of which were approved under the Special Review Procedure for Innovative Medical Devices. The core product, the Magnetic Traction Surgical Field Exposure System, addresses issues such as inadequate exposure of the surgical field in laparoscopic surgery; it has been adopted by more than 50 Grade A tertiary hospitals across China, benefiting thousands of patients. The Staple-Free Magnetic Circular Stapling Device disrupts traditional anastomosis techniques and is currently undergoing multicenter clinical trials. The High-Fidelity Laparoscopic Surgery Training System has obtained international triple-system certification, trained over a thousand young physicians, and generated tens of millions in economic revenue.
On VCBeat's New Product Review
“VCBeat New Product Showcase” is a live-streaming series designed to support healthcare companies in launching innovative products. The program’s mission is to empower the milestone launch of every innovative medical product. If your company has plans to release an innovative medical product or achieve a significant milestone and wishes to participate in the “VCBeat New Product Showcase,” please add our assistant for consultation.